With maintenance PPI therapy, the rate of relapse of esophagitis is 20% or less, which is lower than with H2 blockers (Figure 1.13)
It is not for human consumption or for use in any diagnostic, therapeutic, or clinical applications
For a full plain-language explainer, see our bacteriostatic water research guide
Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography
For detailed cost analysis, see our peptide therapy cost guide and use the peptide cost calculator
This structural mismatch between BPC-157s biology and standard drug development pathways has contributed to the slow pace of clinical trial development, though it has not diminished scientific interest in the compound